Literature DB >> 27102552

Results of revision of total hip arthroplasty for alumina ceramic-on-ceramic bearing fracture.

Rihard Trebše1, Anže Mihelič1, Vesna Levašič1, Andrej Cör1, Ingrid Milošev1.   

Abstract

PURPOSE: The purpose of this study was to compare the results of revision total hip arthroplasty after fracture of primary ceramic components using different type of revision bearing surfaces.
METHODS: We analysed the results of 16 patients with a follow-up more than 3 years after first revision. 6 were revised to ceramic-on-ceramic (CoC) bearing, 9 to metal-on-polyethylene (MoP) and 1 to ceramic-on-cross-linked polyethylene (CoXLP) bearing.
RESULTS: The mean follow-up was 87 months. Patients with revision to CoC had higher Harris Hip Score (HHS) of 89 points in comparison to the patients with revision to MoP with 84 points. Radiographic examinations revealed visible eccentric polyethylene wear with osteolysis in 3 out of 9 patients revised to MoP. There were no detrimental x-ray changes in patients revised to CoC components.
CONCLUSIONS: We consider CoC as the best option at revision operation for ceramic component fracture.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27102552     DOI: 10.5301/hipint.5000340

Source DB:  PubMed          Journal:  Hip Int        ISSN: 1120-7000            Impact factor:   2.135


  3 in total

1.  Fatal Cobalt Toxicity after a Non-Metal-on-Metal Total Hip Arthroplasty.

Authors:  Rinne M Peters; Pax Willemse; Paul C Rijk; Mels Hoogendoorn; Wierd P Zijlstra
Journal:  Case Rep Orthop       Date:  2017-08-27

2.  Cobalt toxic optic neuropathy and retinopathy: Case report and review of the literature.

Authors:  Maria D Garcia; Minjun Hur; John J Chen; M Tariq Bhatti
Journal:  Am J Ophthalmol Case Rep       Date:  2020-01-25

3.  Outcome after Two Sequential Revision Hip Arthroplasties for CoC Bearing Fracture with 10 Years Follow-up: A Case Report.

Authors:  Matevž Topolovec; Ingrid Milošev; Andrej Cör
Journal:  J Orthop Case Rep       Date:  2021-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.